跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
Health Canada
/
YESINTEK I.V.
Authorized
STANDARD
YESINTEK I.V.
Biosimilar Collaborations Ireland Ltd.
🇨🇦 Health Canada
Approval Date
Feb 5, 2026
Approval ID
350232ebf28696c9
Company
Biosimilar Collaborations Ireland Ltd.
Type
Standard
Approval Details
Approval Id
350232ebf28696c9
Drug Approval Canada Name
YESINTEK I.V.
Product Name
YESINTEK I.V.
Status
Marketed
Status Date
2025-10-24
Original Market Date
2025-10-24
Drug Class
Human
Dosage Form
Solution
Route Of Administration
Intravenous
Schedule
Schedule D , Prescription
Ahfs
90:24.20.92
Atc Original
L04AC05 USTEKINUMAB
Aig Number
0152506002
Company Name
Biosimilar Collaborations Ireland Ltd.
Company Address
UNIT 35/36 Grange Parade, Baldoyle Industrial Estate, Dublin 13 Dublin -- Ireland D13R20R
Company Detail Path
/organization/biosimilar-collaborations-ireland-ltd
Company Information
Pharmaceutical Company Name
Biosimilar Collaborations Ireland Ltd.
Country Name
Ireland
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Feb 5, 2026
Approval ID
350232ebf28696c9
Type
Standard
Back to Health Canada Approvals
YESINTEK I.V. - Health Canada Drug Approval Details